Micron Technology

Return on equity -11.69%, ROA -8.40%, ROIC -9.35%. Net income down ▼ +167.1% YoY. Debt/equity 0.09, current ratio 3.42, net debt -$16.15B.

• Return on equity -11.69%, ROA -8.40%, ROIC -9.35%.
• Net income down ▼ +167.1% YoY.
• Debt/equity 0.09, current ratio 3.42, net debt -$16.15B.

Latest annual report (10-K) filed Oct 3, 2025. Latest quarterly report (10-Q) filed Jun 25, 2026. 8 recent 8-K material-event filings in the index.

• Latest annual report (10-K) filed Oct 3, 2025.
• Latest quarterly report (10-Q) filed Jun 25, 2026.
• 8 recent 8-K material-event filings in the index.
• Recent insider Form 4s: 0 buy vs 0 sell transactions.
• ~10,000+ recent 13F-HR filings reference Micron Technology; broad institutional reporting.
• Recent filers include Oak Grove Capital LLC, Oak Grove Capital LLC, Oak Grove Capital LLC.
• 5 recent 13D activist/beneficial-ownership filings — potential catalyst.
• 15 recent 13G passive institutional ownership notices.

5 risk signal(s), 1 positive signal(s), 1 watch item(s) detected from XBRL filing diff analysis. Free cash flow deterioration coincides with a -36.4% capex reduction. While lower capex temporarily preserves cash, it may signal underinvestment in growth assets — future revenue capacity could be constrained.

• Free cash flow deteriorating: FCF declined +296.4% YoY (from $3.11B to $-6.12B). With OCF at $1.56B and capex at $7.68B, cash generation capacity is weakening — monitor for dividend/buyback sustainability.
• NEW: Going concern doubt in latest filing: The term "going concern" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 12 filing(s).
• Material weakness in internal controls: The term "material weakness" appears in 19 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.
• NEW: Substantial doubt about ability to continue in latest filing: The term "substantial doubt" "ability to continue" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 2 filing(s).
• NEW: Restatement of financial statements in latest filing: The term "restate" "financial statements" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 13 filing(s).
• Deferred revenue growing — future revenue visibility: Deferred revenue grew +104.0% to $408.0M, providing forward revenue visibility. This is a positive leading indicator for subscription or contract-based businesses.
• Endogenous analysis: Free cash flow deterioration coincides with a -36.4% capex reduction. While lower capex temporarily preserves cash, it may signal underinvestment in growth assets — future revenue capacity could be constrained.
• Endogenous analysis: The combination of explicit "going concern" language in the filing with deteriorating cash flow or rising leverage is a severe warning signal — the company's own auditors have flagged doubt about the ability to continue as a going concern.
• 5 new XBRL disclosure(s) in latest filing — expanding reporting scope.
• 20 disclosure(s) dropped from prior year — reduced reporting granularity.
• 4 new risk-language term(s) detected in filing text: Going concern doubt, Substantial doubt about ability to continue, Restatement of financial statements, Off-balance sheet arrangements.
• Ongoing high-severity risk language: Material weakness in internal controls.